ASCO - Poster: Radium-223 in an international early access program (EAP): Effects of concomitant medication on overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients

CHICAGO, IL USA ( - Presented by Fred Saad, Joan Carles, Silke Gillessen, Daniel Heinrich, Jeremy Gratt, Kurt Miller, Sten Nilsson, Joe O'Sullivan, Marcello Tucci, Manfred Wirth, and Axel Heidenreich at the American Society of Clinical Oncology (ASCO) Annual Meeting - Illumination & Innovation: Transforming Data into Learning - May 29 - June 2, 2015 - Chicago, Illinois USA

asco 2015 ra223 saad poster



Click HERE to read an exclusive report by a UroToday medical writer

University of Montreal, Montreal, QC, Canada; Vall d'Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona, Spain; Kantonsspital St. Gallen, St. Gallen, Switzerland; Akershus University Hospital, Lørenskog, Norway; Bayer HealthCare, Whippany, NJ; Charité University Medicine Berlin, Berlin, Germany; Karolinska University Hospital, Stockholm, Sweden; Centre for Cancer Research and Cell Biology, Queen's University Belfast and the Northern Ireland Cancer Centre, Belfast, Northern Ireland; Department of Oncology, San Luigi Hospital, Orbassano (Turin), Italy; University Hospital Carl Gustav Carus, Dresden, Germany; University Hospital, RWTH Aachen, Aachen, Germany


email news signup